RENBP and obesity disorder: In this study, we employed an established model of T2DM and obesity (ob/ob mouse) to explore the involvement of the MGO-AGE-RAGE axis in DBD, focusing on the ability of the RAGE inhibitor TTP488 (azeliragon) to reduce the functional and molecular alterations observed in the bladder tissues.